Loading…
Company prepares for distribution of naloxone hydrochloride product.
Scienture Holdings, Inc. announced on 2026-07-09 SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers.
The announcement cited ~$144 million, ~9.8 million units, and more than 100 million covered lives.
Scienture Holdings, Inc. has a free float of 7,919,732 shares and 40,630,815 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.